US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

53.17

-1.0500-1.94%

Post-market: 53.300.1300+0.24%19:10 EDT

Volume:3.88M

Turnover:209.48M

Market Cap:2.16B

PE:- -

High:54.87

Open:54.19

Low:53.04

Close:54.22

52wk High:55.30

52wk Low:24.60

Shares:40.65M

Float Shares:40.65M

Volume Ratio:1.03

T/O Rate:9.54%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24

Australian Clinical Labs lodges 2026 AGM materials and governance disclosures

Australian Clinical Labs publishes AGM materials and 2026 annual report

Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares

Scandium Canada Adds Tech Veteran Noel Dubé to Board to Drive Alloy Commercialization

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Tempus Extends Data Licensing Partnership with Recursion Through November 2029

Tempus AI, Recursion Extend Data License, Amend Fee Structure

MT Newswires Live

Recursion, Tempus Expand AI and RNA Collaboration Agreements

Tempus AI, Recursion extend data license agreement, enter new license agreement

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model

THOMSON REUTERS

Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029

THOMSON REUTERS

Hexcel to showcase advanced composite innovations at CAMX 2026

10x Genomics : Deutsche Bank Raises Target Price to $70 from $40

THOMSON REUTERS

Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target

MT Newswires Live

POSCO FUTURE M Steps Up Global Investor Outreach at Asia Pacific Conference

Pacific Lime and Cement Options Lapse Without Exercise

Aerospace suppliers test rare-earth alternatives to ease reliance on China

Tempus AI EVP, Chief Legal Officer Andrew Polovin Disposes of 2,951 Common Shares for $221,325

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ARKG/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARKG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","market":"US","secType":"STK","nameCN":"ARK Genomic Revolution ETF","latestPrice":53.17,"timestamp":1790884800000,"preClose":54.22,"halted":0,"volume":3877577,"hourTrading":{"tag":"盘后","latestPrice":53.3,"preClose":53.17,"latestTime":"19:10 EDT","volume":40877,"amount":2173832.483188,"timestamp":1790896249977,"change":0.13,"changeRate":0.002445,"amplitude":0.015913},"delay":0,"changeRate":-0.01936554776835111,"floatShares":40650000,"shares":40650000,"eps":0,"marketStatus":"Post-Mkt","change":-1.05,"latestTime":"10-01 19:12:48 EDT","open":54.19,"high":54.8665,"low":53.04,"amount":209479951.465455,"amplitude":0.033687,"askPrice":54,"askSize":42,"bidPrice":53.17,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":54.22,"sharesOutstanding":39900000,"nav":53.923761,"aum":2205481824.9,"bidAskSpread":0.000215,"preHourTrading":{"tag":"盘前","latestPrice":54.01,"preClose":54.22,"latestTime":"09:29 EDT","volume":5797,"amount":316163.71921199997,"timestamp":1790861354855,"change":-0.21,"changeRate":-0.003873,"amplitude":0.013464},"postHourTrading":{"tag":"盘后","latestPrice":53.3,"preClose":53.17,"latestTime":"19:10 EDT","volume":40877,"amount":2173832.483188,"timestamp":1790896249977,"change":0.13,"changeRate":0.002445,"amplitude":0.015913},"volumeRatio":1.025139,"optionData":{"bulkOrders":[{"symbol":"ARKG","call":false,"expireDate":1792123200000,"strike":"53.0","timestamp":1790878889587,"price":1.84,"volume":2000,"amount":368000,"type":"+"},{"symbol":"ARKG","call":false,"expireDate":1792123200000,"strike":"49.5","timestamp":1790878889587,"price":0.55,"volume":2000,"amount":110000,"type":"-"}]},"impliedVol":0.5049,"impliedVolPercentile":0.4223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","floatShares":40650000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.025139,"shares":40650000,"dividePrice":0,"high":54.8665,"amplitude":0.033687,"preClose":54.22,"low":53.04,"week52Low":24.6,"pbRate":"--","week52High":55.3,"institutionHeld":0,"latestPrice":53.17,"committee":0.408451,"eps":0,"divideRate":0,"volume":3877577,"delay":0,"ttmEps":0,"open":54.19,"prevYearClose":28.97,"prevWeekClose":53.36,"prevMonthClose":54.22,"prevQuarterClose":54.22,"fiveDayClose":53.53,"twentyDayClose":47.15,"sixtyDayClose":41.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARKG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-29","symbol":"ARKG","amount":0.38239,"defaultRemindTime":1640788200000,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-29","symbol":"ARKG","amount":0.36456,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2020-12-31","payableDate":"2020-12-30","currency":"USD","type":"dividend","dateTimestamp":1609218000000},{"market":"US","date":"2019-12-27","symbol":"ARKG","amount":1.05395,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2019-12-31","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"market":"US","date":"2018-12-27","symbol":"ARKG","amount":0.26999,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2018-12-31","payableDate":"2018-12-28","currency":"USD","type":"dividend","dateTimestamp":1545886800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARKG\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2018-12-31","value":0.26999,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":1.05395,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.36456,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":0.38239,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARKG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARKG\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669843196","title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843196","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:41","pubTimestamp":1790030476,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics director Ali Behbahani disposes of common shares worth $780,649.24CRISPR Therapeutics director Ali Behbahani exercised stock options for 30,000 common shares at USD 14 on Sept. 17,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL112S6t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","ARKG","BK4139","BK4611","BK4588","BK4585","BK4556","CRSP","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196831","title":"Australian Clinical Labs lodges 2026 AGM materials and governance disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196831?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:33","pubTimestamp":1790030000,"startTime":"0","endTime":"0","summary":"An announcement from Australian Clinical Labs Ltd ( ($AU:ACL) ) is now available. Australian Clinical Labs has released the documentation for its 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-lodges-2026-agm-materials-and-governance-disclosures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-lodges-2026-agm-materials-and-governance-disclosures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","ARKG","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669519688","title":"Australian Clinical Labs publishes AGM materials and 2026 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2669519688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669519688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:33","pubTimestamp":1790029992,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Australian Clinical Labs Ltd ( ($AU:ACL) ). Australian Clinical Labs has released key documents ahead of its 20...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-publishes-agm-materials-and-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-publishes-agm-materials-and-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKG","BK4544","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669119897","title":"Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669119897","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669119897?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:06","pubTimestamp":1790021163,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily M. Leproust disposes of USD 51.47 million in common sharesTwist Bioscience CEO Emily M. Leproust exercised employee stock options for 208,708 shares on Sept. 17, 2026.She so","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL6bV88H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST","WDNA","BK4588","IDNA","BK4585","GNOM","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669988991","title":"Scandium Canada Adds Tech Veteran Noel Dubé to Board to Drive Alloy Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2669988991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669988991?lang=en_us&edition=fundamental","pubTime":"2026-09-22 03:09","pubTimestamp":1790017775,"startTime":"0","endTime":"0","summary":"The latest update is out from Imperial Mining Group Class A ( ($TSE:SCD) ). Scandium Canada Ltd., a Québec-based critical advanced materials compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scandium-canada-adds-tech-veteran-noel-dube-to-board-to-drive-alloy-commercialization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scandium-canada-adds-tech-veteran-noel-dube-to-board-to-drive-alloy-commercialization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","TINT","ARKG","TYNE","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162636","title":"Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162636","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162636?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:18","pubTimestamp":1790007493,"startTime":"0","endTime":"0","summary":"Recursion licenses TxFM RNA foundation model to Tempus AI for oncology use in USD 12 million dealRecursion Pharmaceuticals expanded its data partnership with Tempus AI, extending the term to six years","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL7Y7sX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","LU1861558580.USD","BK4613","TEMT","RXRX","HEAL","BK4539","BK4609","BK4139","TEMC","BK4121","BK4548","ARKG","LU1861559042.SGD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162688","title":"Tempus Extends Data Licensing Partnership with Recursion Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:17","pubTimestamp":1790007444,"startTime":"0","endTime":"0","summary":"Tempus extends data licensing partnership with Recursion through November 2029Tempus extended its multi-year data license partnership with Recursion through November 2029.Deal resets original master a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL8vkn23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4539","BK4613","LU1861559042.SGD","BK4548","TEM","TEMC","ARKG","BK4121","BK4611","HEAL","BK4139","LU1861558580.USD","BK4609","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669161540","title":"Tempus AI, Recursion Extend Data License, Amend Fee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669161540","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669161540?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:36","pubTimestamp":1790001417,"startTime":"0","endTime":"0","summary":"Tempus AI  and Recursion Pharmaceuticals  extended their data license agreement through November 2029 and revised the contract's fee structure.Up to $84 million in discretionary payments over the next two years will be replaced with $42 million in committed payments over three years, Tempus said Monday in a statement.Tempus said it also signed a separate agreement granting the company a nonexclusive, worldwide license to Recursion's proprietary RNA sequencing model.Tempus shares rose 1.8% in Monday trading, and Recursion climbed 2.6%.Price: 79.27, Change: +1.43, Percent Change: +1.83","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861558580.USD","BK4539","LU1861559042.SGD","BK4613","HEAL","RXRX","TEMT","BK4611","BK4548","ARKG","TEM","BK4139","BK4121","TEMC","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169875","title":"Recursion, Tempus Expand AI and RNA Collaboration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169875?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:29","pubTimestamp":1789997370,"startTime":"0","endTime":"0","summary":"The latest update is out from Recursion Pharmaceuticals ( ($RXRX) ). On September 15, 2026, Recursion Pharmaceuticals amended its long-term data an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4139","HEAL","TEM","TEMC","ARKG","BK4539","BK4548","LU1861559042.SGD","LU1861558580.USD","BK4121","BK4613","TEMT","BK4611","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169889","title":"Tempus AI, Recursion extend data license agreement, enter new license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169889?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:20","pubTimestamp":1789996814,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an extension of its data license agreement with Recursion Pharmaceuticals (RXRX). Additionally, the two companies have en...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4609","BK4611","RXRX","BK4613","LU1861558580.USD","ARKG","BK4548","TEMT","BK4139","HEAL","TEM","TEMC","BK4121","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669666681","title":"Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669666681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669666681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4611","BK4613","HEAL","TEM","TEMC","TEMT","LU1861559042.SGD","RXRX","BK4609","LU1861558580.USD","BK4548","BK4121","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166574","title":"Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166574?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","LU1861559042.SGD","ARKG","BK4613","BK4611","BK4539","BK4548","TEM","LU1861558580.USD","TEMC","HEAL","BK4609","TEMT","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166572","title":"Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166572","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166572?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","TEM","HEAL","BK4613","TEMC","ARKG","LU1861559042.SGD","BK4121","BK4548","BK4539","BK4139","BK4609","RXRX","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669816691","title":"Hexcel to showcase advanced composite innovations at CAMX 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669816691","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669816691?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:10","pubTimestamp":1789996244,"startTime":"0","endTime":"0","summary":"Hexcel (HXL) will showcase new materials, qualification milestones and manufacturing innovations at the Composites and Advanced Materials Expo 2026...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hexcel-to-showcase-advanced-composite-innovations-at-camx-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hexcel-to-showcase-advanced-composite-innovations-at-camx-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0240878834.USD","LU0053671581.USD","EES","BK4588","LU0240877869.USD","BZZ","UYM","BK4187","LU0205193047.USD","ROKT","LU0205194284.USD","ARKG","HXL","BK4544","CAMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150390","title":"10x Genomics : Deutsche Bank Raises Target Price to $70 from $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150390?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:58","pubTimestamp":1789988317,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nAQN2MK4RR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4588","LU1861558580.USD","BK4548","LU0963586101.USD","TXG","BK4585","ARKG","FMED","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669915126","title":"Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2669915126","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669915126?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:20","pubTimestamp":1789982440,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $67.94, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861558580.USD","TEMT","BK4611","BK4121","HEAL","TEM","BK4613","LU1861559042.SGD","TEMC","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669135603","title":"POSCO FUTURE M Steps Up Global Investor Outreach at Asia Pacific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2669135603","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669135603?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:42","pubTimestamp":1789951339,"startTime":"0","endTime":"0","summary":"POSCO FUTURE M CO., LTD. ( ($KR:003670) ) has provided an announcement. POSCO FUTURE M CO., LTD. is a materials-focused industrial company that ser...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/posco-future-m-steps-up-global-investor-outreach-at-asia-pacific-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/posco-future-m-steps-up-global-investor-outreach-at-asia-pacific-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4544","ARKG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669151133","title":"Pacific Lime and Cement Options Lapse Without Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2669151133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669151133?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:08","pubTimestamp":1789949304,"startTime":"0","endTime":"0","summary":"The latest update is out from Pacific Lime and Cement Limited ( ($AU:PLA) ). Pacific Lime and Cement Limited, an ASX-listed construction materials ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pacific-lime-and-cement-options-lapse-without-exercise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pacific-lime-and-cement-options-lapse-without-exercise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLBI","IFRA","ARKG","VAW","WOOD","BK4585","RSPM","BK4582","BK4588","DVXB","HALX","IQRA","PLA","BK4544"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669638451","title":"Aerospace suppliers test rare-earth alternatives to ease reliance on China","url":"https://stock-news.laohu8.com/highlight/detail?id=2669638451","media":"Mining","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669638451?lang=en_us&edition=fundamental","pubTime":"2026-09-21 03:29","pubTimestamp":1789932540,"startTime":"0","endTime":"0","summary":"Rare earth shortages are prompting aerospace suppliers to reconsider old turbine coating formulas due to…","market":"us","thumbnail":"https://www.mining.com/wp-content/uploads/2021/03/Gradual-recovery-of-the-aerospace-sector-to-aid-titanium-market-report.jpg","type":0,"news_type":0,"thumbnails":["https://www.mining.com/wp-content/uploads/2021/03/Gradual-recovery-of-the-aerospace-sector-to-aid-titanium-market-report.jpg"],"rights":{"source":"mining_highlight","url":"https://www.mining.com/web/aerospace-suppliers-test-rare-earth-alternatives-to-ease-reliance-on-china/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mining.com/web/aerospace-suppliers-test-rare-earth-alternatives-to-ease-reliance-on-china/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mining_highlight","symbols":["MVPS","NRC","REMX","BK4196","ARKG","FXZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668971630","title":"Tempus AI EVP, Chief Legal Officer Andrew Polovin Disposes of 2,951 Common Shares for $221,325","url":"https://stock-news.laohu8.com/highlight/detail?id=2668971630","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668971630?lang=en_us&edition=fundamental","pubTime":"2026-09-19 09:15","pubTimestamp":1789780544,"startTime":"0","endTime":"0","summary":"Tempus AI EVP, Chief Legal Officer Andrew Polovin disposes of 2,951 common shares for $221,325Tempus AI EVP, Chief Legal Officer Andrew Polovin sold 2,951 Class A common shares on Sep. 17, 2026 at USD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260919:nNDL7xzJg6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI EVP, Chief Legal Officer Andrew Polovin Disposes of 2,951 Common Shares for $221,325","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4611","TEMT","TEM","LU1861558580.USD","LU1861559042.SGD","BK4613","HEAL","TEMC","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}